FDA and the industry should get up to speed on incorporating smartphone apps to provide instructions on OTC drugs, says Saul Shiffman, senior scientific advisor for behavioral science, study design and analysis at pharma industry consultancy Pinney Associates.
Consumers' rampant and still increasing use of mobile apps for all manner of lifestyle, commerce and communications functions demonstrate that the time has come for linking OTC labels with digital tools, said Shiffman, a professor in the departments
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?